Skin melanoma: an analytical literature review and clinical cases
- Authors: Khryanin A.A.1,2, Nadeev A.P.1, Sokolovskaya A.V.1, Vorobyova N.E.3, Chernikova E.V.1
-
Affiliations:
- Novosibirsk State Medical University
- RPO “Association of Obstetricians-Gynecologists and Dermatovenerologists”
- Medical Center “Microbiomed”
- Issue: Vol 32, No 5 (2025)
- Pages: 41-48
- Section: Reviews
- URL: https://journals.eco-vector.com/2073-4034/article/view/691255
- DOI: https://doi.org/10.18565/pharmateca.2025.5.41-48
- ID: 691255
Cite item
Abstract
Melanoma, a malignant melanocytic tumor, remains one of the most aggressive forms of malignant skin tumors and is a significant public health problem. Despite progress in early diagnosis and treatment, melanoma continues to be the leading cause of death from skin cancer. The development of skin melanoma (SM) is a multistage process involving a complex relationship between genetic mutations, signaling pathways, and the tumor microenvironment. The main risk factors for SM remain unchanged, including ultraviolet radiation, genetic predisposition, phenotype, immunosuppression, and patient age. Advances in molecular biology have identified key signaling pathways involved in the development of SM. Mutations in the BRAF, NRAS, KIT, and NF1 genes are the most common. Melanoma is characterized by a complex interaction with the immune system. The cellular immune response, which involves cytotoxic T lymphocytes (CTLs), is important for tumor control, but melanoma is able to suppress this response. SM is a complex and heterogeneous disease. In recent years, significant progress has been made in understanding the molecular mechanisms and developing new treatments. However, further research to improve treatment outcomes and prevent this disease is required. Early diagnosis is critical for a favorable prognosis. The authors present clinical cases of melanocytic skin cancer from personal practice.
Keywords
Full Text

About the authors
Aleksey A. Khryanin
Novosibirsk State Medical University; RPO “Association of Obstetricians-Gynecologists and Dermatovenerologists”
Author for correspondence.
Email: khryanin@mail.ru
ORCID iD: 0000-0001-9248-8303
Dr. Sci. (Med.), Professor of the Department of Dermatovenereology and Cosmetology
Russian Federation, Novosibirsk; NovosibirskAleksandr P. Nadeev
Novosibirsk State Medical University
Email: khryanin@mail.ru
ORCID iD: 0000-0003-0400-1011
Dr.Sci. (Med.), Head of the Department of Pathological Anatomy
Russian Federation, NovosibirskAsya V. Sokolovskaya
Novosibirsk State Medical University
Email: khryanin@mail.ru
ORCID iD: 0000-0002-3131-7874
Cand. Sci. (Med.), Associate Professor, Department of Dermatovenereology and Cosmetology
Russian Federation, NovosibirskNadezhda E. Vorobyova
Medical Center “Microbiomed”
Email: khryanin@mail.ru
ORCID iD: 0000-0002-7811-5049
Cand. Sci. (Med.), Dermatovenereologist
Russian Federation, St. PetersburgEvgeniya V. Chernikova
Novosibirsk State Medical University
Email: khryanin@mail.ru
ORCID iD: 0000-0002-9297-6064
Cand. Sci. (Med.), Associate Professor, Department of Dermatovenereology and Cosmetology
Russian Federation, NovosibirskReferences
- Клинические рекомендации «Меланома кожи и слизистых оболочек». 2023. Электронный ресурс. Дата обращения: 02.05.2025. [Clinical guidelines «Cutaneous and mucosal melanoma». 2023. Electronic resource. Date of access: 02.05.2025. (In Russ.)].
- Злокачественные новообразования в России в 2021 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. Москва: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2022. [Malignant neoplasms in Russia in 2021 (incidence and mortality). Edited by A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. Moscow: P.A. Herzen Moscow Oncology Research Institute – branch of the National Medical Research Center of Radiology of the Ministry of Health of the Russian Federation, 2022. (In Russ.)].
- Эркенова Ф.Д., Пузин С.Н. Статистика меланомы в России и странах Европы. Медико-социальная экспертиза и реабилитация. 2020;23(1):44–52. [Erkenova F.D., Puzin S.N. Statistics of melanoma in Russia and European countries. Medical and social examination and rehabilitation. 2020;23(1):44–52. (In Russ.)]. doi: 10.17816/MSER34259
- Garbe C., Amaral T., Peris K., et al. European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022. Eur J Cancer . 2022;170:236–255. doi: 10.1016/j.ejca.2022.03.008
- Marquez-Rodas I., Munoz Couselo E., Rodriguez Moreno J.F., et al. SEOM-GEM clinical guidelines for cutaneous melanoma (2023). Clin Transl Oncol. 2024;26(11):2841–2855. doi: 10.1007/s12094-024-03497-2
- Whiteman D.C., Neale R.E., Aitken J. When to apply sunscreen: a consensus statement for Australia and New Zealand. Aust N Z J Public Health. 2019;43:171–175. doi: 10.1111/1753-6405.12873
- Кутилин Д.С., Зварич А.М., Позднякова В.В. и соавт. Меланома кожи: эпидемиология, этио-логия и молекулярно-генетические основы патогенеза. Современные проблемы науки и образования (сетевое издание). 2025;1. [Kutilin D.S., Zvarich A.M., Pozdnyakova V.V. et al. Skin melanoma: epidemiology, etiology and molecular genetic basis of pathogenesis. Modern problems of science and education (online publication). 2025;1. (In Russ.)]. doi: 10.17513/spno.33936
- Гайдина Т.А., Дворников А.С., Пацап O.И. и соавт. Первично множественные злокачественные опухоли кожи: меланома и базальноклеточный рак. Вестник дерматологии и венерологии. 2023;99(2):48–62. [Gaidina T.A., Dvornikov A.S., Patsap O.I. et al. Primary multiple malignant skin tumors: melanoma and basal cell carcinoma. Vestnik Dermatologii and Venereologii. 2023;99(2):48–62. (In Russ).]. doi: 10.25208/vdv1415
- Красносельских Т.В., Аравийская Е.Р., Соколовский Е.В., Монахов К.Н. Справочник практического врача по наиболее часто встречающимся дерматозам. М.: ИндексМед Медиа, 2023. 600 с. [Krasnoselskikh T.V., Araviyskaya E.R., Sokolovsky E.V., Monakhov K.N. Handbook of a practical physician on the most common dermatoses. Moscow: IndexMed Media, 2023. 600 p. (In Russ.)].
- Еремина Е.Н., Караханян А.Р., Вахрунин Д.А. и соавт. Молекулярно-генетические маркеры пигментной меланомы кожи (обзор литературы). Сибирское медицинское обозрение. 2020;(3):38–46. [Eremina E.N., Karakhanyan A.R., Vakhrunin D.A. et al. Molecular genetic markers of pigmented melanoma of the skin (literature review). Siberian Medical Review. 2020;(3):38–46. (In Russ.)]. doi: 10.20333/2500136-2020-3-38-46
- Григорук О.Г., Пупкова Е.Э., Базулина Л.М., Вихлянов И.В. Диагностика метастатической меланомы методом тонкоигольной аспирационной биопсии и первичной меланомы по отпечаткам с кожи и слизистых оболочек. Российский онкологический журнал. 2023;28(3):119–129. [Grigoruk O.G., Pupkova E.E., Bazulina L.M., Vikhlyanov I.V. Diagnostics of metastatic melanoma by fine-needle aspiration biopsy and primary melanoma by skin and mucous membrane imprints. Russian Journal of Oncology. 2023;28(3):119–129. (In Russ).]. doi: 10.17816/onco626586
- Armstrong B.K. Kricker A. Cutaneous melanoma. Cancer Surv. 1994;19–20:219–240.
- Fitzpatrick T.B. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol. 1988;124:869–871.
- Bauer J., Buttner P., Wiecker T.S. Effect of sunscreen and clothing on the number of melanocytic nevi in 1,812 German children attending day care. Am J Epidemiol. 2005;161:620–627. doi: 10.1093/aje/kwi086
- Grau-Pérez M., Borrego L., Carretero G. et al. Assessing the effect of environmental and socio-economic factors on skin melanoma incidence: an island-wide spatial study in Gran Canaria (Spain), 2007-2018. Cancer Causes Control. 2022;33(10):1261–1272. doi: 10.1007/s10552-022-01614-6
- IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Radiation; IARC Monogr Eval Carcinog Risks Hum. 2012;100:7–303.
- Олисова О.Ю., Притуло О.А., Кирилюк Т.И. К вопросу о диагностике меланоцитарных новообразований (обзор литературы). Российский журнал кожных и венерических болезней. 2020;23(5):278–287. [Olisova O.Yu., Pritulo O.A., Kirilyuk T.I. On the issue of diagnostics of melanocytic neoplasms (literature review). Russian Journal of Skin and Venereal Diseases. 2020;23(5):278–287. (In Russ.)]. doi: 10.17816/dv48837
- Неретин Е.Ю., Титов К.С., Запиров Г.М. Первичная ранняя диагностика меланомы кожи после индивидуального обучения врачей. Клиническая дерматология и венерология. 2023;22(1):99–105. [Neretin E.Yu., Titov K.S., Zapirov G.M. Primary early diagnostics of skin melanoma after individual training of doctors. Russian Journal of Clinical Dermatology and Venereology. 2023;22(1):99–105. (In Russ.)]. doi: 10.17116/klinderma20232201199
- Friedman R.J., Rigel D.S., Kopf A.W. Early detection of malignant melanoma: the role of physician examination and self-examination of the skin. CA Cancer J Clin. 1985 May-Jun;35(3):130–51. doi: 10.3322/canjclin.35.3.130
- Abbasi N.R., Shaw H.M., Rigel D.S., et al. Early diagnosis of cutaneous melanoma: revisiting the ABCD criteria. JAMA. 2004;292(22):2771–2776. doi: 10.1001/jama.292.22.2771
- Menzies S.W., Ingvar C., McCarthy W.H. A sensitivity and specificity analysis of the surface microscopy features of invasive melanoma. Melanoma Res. 1996;6(1):55–62. doi: 10.1097/00008390-199602000-00008
- Хрянин А.А., Бочарова В.К. Искусственный интеллект в дерматологии: возможности и перспективы. Клиническая дерматология и венерология. 2024;23(3):246–252. [Khryanin A.A., Bocharova V.K. Artificial intelligence in dermatology: possibilities and prospects. Russian Journal of Clinical Dermatology and Venereology. 2024;23(3):246–252. (In Russ.)]. doi: 10.17116/klinderma202423031246
- Бухаров А.В., Сарибекян Э.К., Вертиева Е.Ю. и соавт. Подногтевая меланома. Клиническая дерматология и венерология. 2024;23(1):38–44. [Bukharov A.V., Saribekyan E.K., Vertieva E.Yu. et al. Subungual melanoma. Russian Journal of Clinical Dermatology and Venereology. 2024;23(1):38–44. (In Russ.)]. doi: 10.17116/klinderma20242301138
- Александрова Л.М., Мамонтов А.С., Богданова Н.В. и соавт. «День диагностики меланомы» в России – направление работы по скринингу и раннему выявлению злокачественных новообразований. Поволжский онкологический вестник. 2011;1:6–7. [Aleksandrova L.M., Mamontov A.S., Bogdanova N.V. et al. «Melanoma Diagnostics Day» in Russia – a direction of work on screening and early detection of malignant neoplasms. Oncologу Bulletin of the Volga region. 2011;1:6–7. (In Russ.)].
- Zhang M., Qureshi A.A., Geller A.C., et al. Use of tanning beds and incidence of skin cancer. JClin. Oncol. 2012;30:1588–1593. doi: 10.1200/JCO.2011.39.3652
- Veierod M.B., Couto E., Lund E., et al. Host characteristics, sun exposure, indoor tanning and risk of squamous cell carcinoma of the skin. Int J Cancer. 2014;135:413–422. doi: 10.1002/ijc.28657
- Stenehjem J.S., Robsahm T.E., Bratveit M., et al. Ultraviolet radiation and skin cancer risk in offshore workers. Occup Med. 2017;67:569–573. doi: 10.1093/occmed/kqx110 Christensen G.B., Ingvar C., Hartman L.W., et al. Sunbed use increases cutaneous squamous cell carcinoma risk in women: a large-scale, prospective study in Sweden. Acta Derm. Venereol. 2019;99:878–883. doi: 10.2340/00015555-3198.
- Lergenmuller S., Ghiasvand R., Robsahm T.E., et al. Association of lifetime indoor tanning and subsequent risk of cutaneous squamous cell carcinoma. JAMA Dermatol. 2019;155:1350–1357. doi: 10.1001/jamadermatol.2019.2681.
- Veierod M.B., Adami H.O., Lund E., et al. Sun and solarium exposure and melanoma risk: Effects of age, pigmentary characteristics, and nevi. Cancer Epidemiol. Biomarkers Prev. 2010;19:111–120. doi: 10.1158/1055-9965.EPI-09-0567
- Nielsen K., Masback A., Olsson H., Ingvar C. A prospective, population-based study of 40,000 women regarding host factors, UV exposure and sunbed use in relation to risk and anatomic site of cutaneous melanoma. Int J Cancer. 2012;131:706–715. doi: 10.1002/ijc.26408
- Ghiasvand R., Robsahm T.E., Green A.C., et al. Association of phenotypic characteristics and UV radiation exposure with risk of melanoma on different body sites. JAMA Dermatol. 2019;155:39–49. doi: 10.1001/jamadermatol.2018.3964
- An S., Kim K., Moon S., et al. Indoor Tanning and the Risk of Overall and early-onset melanoma and non-melanoma skin cancer: systematic review and meta-analysis. Cancers (Basel). 2021;13(23):5940. doi: 10.3390/cancers13235940
- Mitchell D.L. Greinert R. de Gruijl F.R. Effects of chronic low-dose ultraviolet B radiation on DNA damage and repair in mouse skin. Cancer Res. 1999;59:2875–2884.
Supplementary files
